Mark Bernard

Mark Bernard is an Associate Professor in the Department of Radiation Medicine at the University of Kentucky, with concurrent appointments at the Markey Cancer Center and Cancer Research Priority Initiative. His work focuses on advancing radiation therapy techniques for complex cancers.

• Education:
  • Bachelor of Science, Carnegie-Mellon University (2005)
  • Doctor of Medicine, University of Pittsburgh (2012)
  • Residency, University of Pittsburgh (2017)

Research

Dr. Bernard's research spans Radiation Oncology, Medical Physics, and Immunotherapy, with key contributions to stereotactic body radiation therapy (SBRT), lattice radiotherapy algorithms, and radiation-immunotherapy combinations for stage IV cancers. Current projects include:

• CRIBS Trial: Concurrent radiation-immunotherapy for metastatic EGG cancers
• Halcyon Linac Optimization: Single-isocenter multi-lesion targeting
• Radioprotector Development: For rectal cancer toxicity reduction

Awards

• Medical Student Rotation Award for Underrepresented Populations (2011)

Collaborations

Active in translational oncology research, he collaborates with institutions like Varian Medical Systems, Carina Medical LLC, and University of Nebraska Omaha on adaptive therapy and AI-driven segmentation projects.